Novel Lipid Thresholds for Screening Predict the Need for Pharmacotherapy

Area of Science:

• Pediatric Cardiology
• Lipid Metabolism
• Preventive Medicine

Background:

• Pediatric lipid screening guidelines aim to identify children at risk for cardiovascular disease.
• Current non-fasting lipid screening may lead to unnecessary follow-up tests and patient burden.
• Optimizing screening thresholds is crucial for effective and efficient preventive care.

Purpose of the Study:

• To establish more predictive non-high-density lipoprotein cholesterol (non-HDL-C) and high-density lipoprotein cholesterol (HDL-C) thresholds for pediatric non-fasting lipid screens.
• To estimate the number of potentially avoidable fasting lipid panels in children and adolescents.
• To identify thresholds that better predict the need for lipid-lowering pharmacotherapy.

Main Methods:

• Retrospective review of lipid results and clinical data in children and youths aged 8-21 years.
• Receiver operating characteristic (ROC) curve analysis to determine threshold lipid values.
• Application of identified thresholds to screening populations to calculate rates of unnecessary fasting panels.

Main Results:

• Higher non-HDL-C thresholds (>156 mg/dL for those with risk factors, >199 mg/dL for those without) showed high sensitivity for predicting pharmacotherapy recommendation.
• These thresholds offered improved specificity, positive predictive value, and negative predictive value compared to current guidelines.
• HDL-C was found to be a poor predictor of the need for pharmacotherapy.

Conclusions:

• Implementing revised non-HDL-C and HDL-C thresholds can reduce unnecessary follow-up fasting lipid panels.
• This strategy can decrease patient anxiety, healthcare costs, and time associated with testing.
• Improved screening efficiency may enhance compliance with universal pediatric lipid screening protocols.